About Hiro Yasuda, MD

Clinical Interests:




Mass General Imaging
55 Fruit St.
Boston, MA 02114
Phone: 617-724-9729

Medical Education

  • MD, Fukushima Medical University
  • Residency, Fukushima Medical University
  • Residency, Long Beach Memorial Medical Center
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Nuclear Medicine, American Board of Nuclear Medicine


General Theme:  Coronary Artery Disease And Treatment: Thrombolysis was introduced at MGH with Dr. Gold and Dr. Leinbach in 80's. Now I am interested in preventing atherosclerosis and peripheral artery disease including coronary artery disease. Both  treatment and diagnostic Imaging are my interests

Hyperlipidemia:  As part of above interest, I have been conducting Cholesterol transfer protein Inhibitor research in human as a Principle investigator at MGH.

Cardiac Imaging ( Nuclareat cardiology and molecular Imaging): Using my training in research and clinical expertise, new imaging agents have been investigated and currently a new PET imaging agent  for myocardial perfusion and stress testing has been investigated as a part of multicenter trial. In addition, other metabolic imaging agents have been investigated: Free Fatty acid and myocardial imaging. Norepinephrine transporter imaging in heart failure patient.

PET and CT:  Molecular dynamics of Myocardium or vasculature  are key to understanding aging process as well as pathological process of cardiovascular illness. These imaging technology would provide a new insight and combined knowledge of anatomical and the state of molecular Cell Biology. Currently multiple studies have been planned.


  • Original Articles

    Yasuda T, Palacios IF, Dec GW, Fallon JT, Gold HK, Leinbach RC, Strauss HW, Khaw BA, Haber:  Indium-111 monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis.  Circulation 1987; 76:306-311.

    Yasuda T, Gold HK, Leinbach RC, Saito T, Guerrero JL, Jang IK, Holt R, Fallon JT, Collen D.  Lysis of rt-PA resistant platelet-rich coronary arterial thrombus with combined bolus injection of recombinant tissue-type plasminogen activator (rt-PA) and anti-platelet GPIIIa antibody.  J Am Coll Cardiol 1990; 16:1728-35.

    Akutsu, Y, Gregory, S, Kardan A, Zervos GD, Thomas GS, Gewirtz H,  Yasuda T. Delayed heart rate recovery after adenosine stress testing with supplemental arm exercise predicts mortality.  J Nuc Cardiol 2009; 16: 54-62.

Reviews: Comments and Ratings